Patent 5762805 Issued on June 9, 1998. Estimated Expiration Date: June 9, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
210/645, Biological fluid (e.g., blood, urine, etc.)210/646, Hemodialysis210/739, Including controlling process in response to a sensed condition210/929, HEMOULTRAFILTRATE VOLUME MEASUREMENT OR CONTROL PROCESSES604/6.09Filter means
Blood from a patient is treated extracorporeally by any selected one of a plurality of predetermined treatments. Each of the treatments involves the flow of blood from the patient into a primary chamber of a filtration unit, past a semipermeable membrane located in the filtration unit which separates the primary chamber from a secondary chamber of the filtration unit, out the filtration unit and back to the patient. A replacement fluid is selectively and controllably added to the blood, as required for the selected treatment. A secondary fluid is controllably and selectively introduced into the secondary chamber of the filtration unit for controllably collecting material passing across the semipermeable membrane from the blood or for supplying material to pass across the semipermeable membrane into the blood as required for the selected treatment. Materials are removed from the secondary chamber and collected in accordance with the selected treatment. Blood leaks into the secondary chamber are automatically detected and the rates of blood and fluid flow automatically adjusted in response thereto. An apparatus which automatically performs and monitors the selected treatment is also described.
Other References
J.V. Leins, M.D., et al., "Arteriovenous Hemofiltration with Dialysis", Critical Care Report 1990, pp. 408-414
"Buffer Balance in Bicarbonate Hemofiltration", American Society for Artificial Internal Organs 32, Jul.-Sep. 1986, No. 1, Hagerstown, MD, USA, pp. 422-424
Gambro.RTM., "Operator's Manual for Hemofiltration BMM 10-1 and HFM 10-1", AK-10 System for Hemofiltration, GambroAB, Lund Sweden. (1986)
R.L. Menta, "New Developments in Continous Arteriovenous Hemofiltration/Dialysis", International Yearbook of Nephrology 1992, pp. 271-295
Renal Intensive Care Program, Hospal Ltd., Basel, Switzerland. (undated)
"MONITRAL.RTM.S Biofiltration Acetate Free" and MONITRAL.RTM.SC Biofiltration Acetate Free, Hospal publ. in or before Jan. 1993, Meyzieu Cedex, France
"COBE Centrysystem™ 3 Dialysis Control Unit--Operator's Manual", COBE Laboratories, Inc. Sep. 1988, Lakewood, Colorado
"International Standard--Medical Electrical Equipment Part 2: Particular requirements for safety of haemodialysis equipment", IEC, pp. 31 and 35, 1989, Brussels, Belgium
"Hemofilter and Hemoprocessor--A New System for Hemofiltration", Sartorius-Membranfilter GmbH, publ. on or before Jan. 29, 1993. Gottingen, Germany
"Instruction Manual BSM 22SC", Rev. A, pp. 29, 30 and 57, Hospal Mar. 1990, Meyzieu Cedex, France
J.H. Holmes et al., "Removal of Fluid From the Patient During Hemodialysis", Dept. of Medicine, Univ. of Colorado, 1969
"International Standard CEI IEC 601-2-16", .COPYRGT.1989 Bureau International Electrotechnical Commission, Geneva, Switzerland
"Centrysystem™ 3--Precise Ultrafiltration Control", .COPYRGT.1987 COBE Laboratories, Inc. Lakewood, Colorado
"Hemofiltration in Perspective", 1988 Gambro Ltd., Sidcup, United Kingdom
C. Ronco et al., "Technical and Clinical Evaluation of a New System for Ultrafiltration Control During Hemodialsis", 1988 Tran. Amer. Society Artif. Intern. Organs, pp. 613-61
June 9, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
